1,489 results on '"Huguet F"'
Search Results
52. PO-1104 Ethics and professionalism in French medical physicist community: survey results and implications.
53. Gangliocytome hypophysaire et maladie de Cushing : à propos d’un cas
54. Intensity modulated radiation therapy in nasopharyngeal carcinoma
55. Irradiation conformationnelle avec modulation d’intensité des cancers du rhinopharynx
56. Radiation therapy for locally advanced pancreatic adenocarcinoma: a therapeutic option which should not be forgotten. Letter to the Editor regarding: "Pancreatic cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up" by Huguet et al
57. Tracheal Cancers
58. Locally Advanced Pancreatic Cancer: The Role of Definitive Chemoradiotherapy
59. Chimioradiothérapie de rattrapage à visée curative de rechutes pelviennes isolées de cancers du col utérin
60. Function and regulation of TRPM7, as well as intracellular magnesium content, are altered in cells expressing ΔF508-CFTR and G551D-CFTR
61. Cardiovascular risk profile of patients with peripheral arterial occlusive disease during nilotinib therapy
62. Repo-Man/PP1 SUMOylation mediates binding to lamin A and Serine 22 dephosphorylation
63. Recommandations pour la pratique clinique Cancer du rectum: Question 1 Comment choisir les thérapeutiques néo-adjuvantes ?
64. Place de la radiothérapie (et chimioradiothérapie) dans les cancers localement avancés ou borderline. Quelles perspectives ?
65. Brèves de l’AERIO: Chimiothérapie première versus chirurgie première dans les cancers de l’ovaire avancés nouvellement diagnostiqués (CHORUS) : essai de phase III de non-infériorité [1]
66. P705: MULTI-CENTER CHART REVIEW STUDY EXAMINING TREATMENT PATTERNS AND CLINICAL OUTCOMES AMONG PATIENTS WITH CHRONIC PHASE (CP) CHRONIC MYELOID LEUKEMIA (CML) TREATED IN THIRD-LINE (3L) OR LATER IN FRANCE
67. P477: PHENOTYPICALLY-DEFINED STAGES OF LEUKEMIA ARREST PREDICT MAIN DRIVER MUTATIONS SUBGROUPS, AND OUTCOME IN ACUTE MYELOID LEUKEMIA
68. OC-0108 Impact of the Radiation Therapy Quality Assurance in the phase II/III CONCORDE trial.
69. MO-0226 Clinical outcomes of HIV-positive patients with anal cancer in the ANABASE multicentric cohort
70. Nouvelles techniques de radiothérapie des tumeurs de la face et du cou : état des lieux et perspectives
71. Disseminated and circulating tumor cells in gastrointestinal oncology
72. Occupational Exposure to Pesticides and Lymphoid Neoplasms among Men: Results of a French Case-Control Study
73. Allogeneic and Autologous Bone Marrow Transplantation and Chemotherapy in First Remission of Adult Acute Lymphoblastic Leukemia: Results of the LALA 87 Trial of the French Group
74. Cigarette Smoking, Alcohol Drinking, and Risk of Lymphoid Neoplasms: Results of a French Case–Control Study
75. UV Radiation Exposure, Skin Type and Lymphoid Malignancies: Results of a French Case-Control Study
76. Mécanismes de carcinogenèse des cancers du pancréas : quelles pistes pour la radiosensibilisation ?
77. Radiation therapy of pancreatic cancers
78. Étude Raibeca : radiotherapy for inflammatory breast cancer
79. Efficacité et toxicité de la (chimio)radiothérapie chez les patients séropositifs pour le VIH atteints d’un carcinome épidermoïde du canal anal, analyse en sous-groupe de la cohorte multicentrique Anabase
80. Évaluation du questionnement éthique en radiothérapie
81. Prospective Study Comparing Idarubicin and Daunorubicin in Elderly Patients with Acute Myeloid Leukemia
82. Cancer du pancréas
83. Dose de tolérance à l’irradiation des tissus sains : le rein
84. Place de l’irradiation stéréotaxique hypofractionnée dans le traitement des métastases cérébrales
85. PO-1263 Exclusive radiotherapy in early stage anal cancer - outcomes, patterns and predictors of relapse
86. 853O OMITting frontline chemotherapy in head and neck cancer (HNSCC) patients with 1-3 oligometastases using stereotactic ablative radiotherapy (SABR), the GORTEC 2014-04 “OMET” randomized phase II trial
87. Results of investigations to design a monitoring program for a CO2 storage project in the Paris Basin (France)
88. Compensation électronique dans les traitements de cancer du sein par irradiation : utilisation des radiographies numériques reconstruites ( digital reconstruct radiograph [DRR])
89. Flow cytometry and IG/TCR quantitative PCR for minimal residual disease quantitation in acute lymphoblastic leukemia: a French multicenter prospective study on behalf of the FRALLE, EORTC and GRAALL
90. RET fusion genes are associated with chronic myelomonocytic leukemia and enhance monocytic differentiation
91. First-line imatinib mesylate in patients with newly diagnosed accelerated phase-chronic myeloid leukemia
92. Le diagnostic de la leucémie myéloïde chronique (LMC) en 2012
93. Is Early Response to Chemotherapy a Useful Prognostic Factor in Adult Acute Lymphoblastic Leukemia
94. Apport de la TEP au diagnostic, évaluation thérapeutique et suivi du cancer de l’œsophage
95. Toxicity Profile of Idarubicin: Experiences with Oral and Intravenous Idarubicin in the Treatment of Leukemia
96. Point de vue sur les traitements adjuvant et néoadjuvant du cancer du pancréas en 2010
97. PAX5 mutations occur frequently in adult B-cell progenitor acute lymphoblastic leukemia and PAX5 haploinsufficiency is associated with BCR-ABL1 and TCF3-PBX1 fusion genes: a GRAALL study
98. Club 35 Poster session Friday 13 December: 13/12/2013, 08: 30–18: 00Location: Poster area
99. Moderated Posters sessionCongenital heart disease: 12/12/2013, 14: 00–18: 00Location: Moderated Poster area
100. Outcome of treatment after first relapse in adults with acute lymphoblastic leukemia initially treated by the LALA-94 trial
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.